A rterial stiffening is associated with cardiovascular morbidity, such as myocardial infarction, heart failure, and stroke, but also with dementia and renal failure. 1 Central aortic elasticity can be measured by pulse wave velocity, 2 and increased pulse wave velocity is a strong and independent predictor of cardiovascular morbidity and all-cause mortality in patients with essential hypertension, 3 end-stage renal disease, 4 as well as the general population. 5 The overall vascular elasticity reflects the mechanical property of the large arteries and is the result of individual genetic predisposition, 6 lifestyle, other environmental factors, and their interaction. 7 Vascular elasticity and compliance of the vascular wall depend to a great extent on the relative contribution of the scaffolding proteins elastin and collagen. 8 Dysregulation of their expression, degradation, and protein cross-links may lead to alterations in the elastin/collagen ratio with subsequent arterial stiffening. 9 The mineralocorticoid hormone aldosterone is a potent and blood pressure-independent inducer of both, elastin and collagen expression, 10 pointing to the direct implication of aldosterone in vascular elasticity. Most recently, the involvement of the vascular endothelium has been discussed extensively as an important regulator of vascular elasticity. 11 Endothelial cells (ECs) contribute to the vascular tone and are sensitive to aldosterone and elevated sodium concentrations. 12 Regulation of endothelial stiffness involves the multi-subunit epithelial sodium channel (ENaC) and potentially the Na + / K + -ATPase. 11, 13 Gene expression of ENaC-α (SCNN1A), Na + / K + -ATPase-α/-β (ATP1A1, ATP1B1), and the mineralocorticoid receptor (MR; NR3C2) has been suggested to depend on the second messenger cAMP. [14] [15] [16] [17] The human adenylyl cyclase 10 (ADCY10), also termed soluble adenylyl cyclase (sAC), generates cAMP in the cellular nucleus 18, 19 with subsequent protein kinase A (PKA) activation and cAMP response element-binding protein (CREB) phosphorylation. In the kidney, sAC has been reported to be involved in blood pressure homeostasis, whereas specific inhibition of sAC by its inhibitor KH7 resulted in abrogation of basic and agonist-stimulated Na + reabsorption. 20 ENaC, Na + /K + -ATPase, and MR expression may involve binding of phosphorylated CREB (CREB-p) to cAMP response elements (CRE) at the promoter level. [21] [22] [23] In
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-and bicarbonate-activated soluble adenylyl cyclase (sAC) has been identified recently as an important mediator of aldosterone signaling in the kidney. Nuclear sAC has been reported to stimulate cAMP response elementbinding protein 1 phosphorylation via protein kinase A, suggesting an alternative cAMP pathway in the nucleus. In this study, we analyzed the sAC as a potential modulator of endothelial stiffness in the vascular endothelium. We determined the contribution of sAC to cAMP response element-mediated transcriptional activation in vascular endothelial cells and kidney collecting duct cells. Inhibition of sAC by the specific inhibitor KH7 significantly reduced cAMP response element-mediated promoter activity and affected cAMP response element-binding protein 1 phosphorylation. Furthermore, KH7 and anti-sAC small interfering RNA significantly decreased mRNA and protein levels of epithelial sodium channel-α and Na + /K + -ATPase-α. Using atomic force microscopy, a nano-technique that measures stiffness and deformability of living cells, we detected significant endothelial cell softening after sAC inhibition. Our results suggest that the sAC is a regulator of gene expression involved in aldosterone signaling and an important regulator of endothelial stiffness. Additional studies are warranted to investigate the protective action of sAC inhibitors in humans for potential the current work, we analyzed sAC-dependent CRE-mediated transcriptional activation through CREB-p in kidney and ECs and determined the impact of sAC on endothelial stiffness.
Methods
Cell Culture
The human vascular EC line EA.hy926 24 was maintained in DMEM (Sigma-Aldrich, Munich, Germany) with 10% fetal calf serum (PAA, Cölbe, Germany), penicillin (100 U/mL), streptomycin (100 ng/mL), and l-glutamine (2 mmol/mL; all Sigma-Aldrich). The human kidney epithelial cell line IHKE [25] [26] [27] was maintained in DMEM/Ham's-F12, 1% fetal calf serum, penicillin (100 U/mL), streptomycin (100 ng/ mL), and l-glutamine (2 mmol/mL), insulin-transferrin-sodium selenite media supplement (10 μL/mL), NaHCO 3 (1.25 μg/mL), sodium pyruvate (55 μg/mL), epidermal growth factor (10 μg/L; all Sigma-Aldrich,) and HEPES (15 μmol/mL, Merck, Darmstadt, Germany). Human primary aortic ECs (PromoCell, Heidelberg, Germany) were maintained in endothelial cell growth medium MV with 10% fetal calf serum, epidermal growth factor (10 ng/mL), and hydrocortisone (1 μg/mL; all PromoCell). Cells were incubated with 500 μmol/L lipophilic 8-Br-cAMP (Biolog, Bremen, Germany) or 200 pmol/L aldosterone (Sigma-Aldrich) as indicated. The specific sAC inhibitor KH7 (Sigma-Aldrich) was administered at a concentration of 25 μmol/L, the MR antagonist spironolactone (Sigma-Aldrich) at 1 μmol/L.
Preparation of Mice Aortae
All animal experiments were approved by an institutional review committee. Mice aortae (n=4) for atomic force microscopy (AFM)-based cell stiffness measurements were dissected, freed from surrounding tissue, opened and fixed on glass coverslips coated with Cell-Tak (Becton Dickinson, Heidelberg, Germany) as described previously. 28 Aortae were incubated for 24 hours in medium with KH7 (25 μmol/L) and aldosterone (1 nmol/L) or aldosterone alone.
AFM-Based Cell Stiffness Measurements
The stiffness (defined as Newton per meter) of EA.hy926 cells and in situ ECs of ex vivo mice aorta was measured at 37°C using a Multimode AFM (Bruker, Mannheim, Germany) equipped with a soft cantilever (MLCT-contact microlever, spring constant: 0.018 N/m for ECs, 0.011 or 0.012 N/m for aortae; Bruker) and a spherical tip with a diameter of 1 μm for ECs and 10 μm for aortae (Novascan, Ames, IA) as described previously. 12 Cantilever deflection from the cell surface (indentation depth, ≈50-100 nm) was measured by laser beam and transformed into single-cell force/distance curves. For each experimental condition, 20 single-cell measurements with 8 force/distance curves per cell were recorded. During AFM measurements, cells were kept in HEPES-buffered solution (140 mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L MgCl 2 , 1 mmol/L CaCl 2 , 10 mmol/L HEPES, 5 mmol/L glucose, pH 7.4). AFM data were collected with the NanoScope V8.10 software (Bruker) and stiffness values were calculated using the Protein Unfolding and Nano-Indentation Analysis Software (http://punias.voila.net/).
Transient Transfections and siRNA Experiments
For details please see online-only Data Supplement.
Real-Time Polymerase Chain Reaction
Preparation of Nuclear Protein Extracts
Nuclear protein extracts were generated using a modified protocol. 29 For details please see online-only Data Supplement.
Western Blot
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) was performed as described previously. 30 DNA/protein complexes were fixed using formaldehyde (1%, 30 minutes). DNA was sonicated using a Bioruptor (≈45 minutes, 0.5-second interval, 200 W; Diagenode, Liège, Belgium). Chromatin had an average size of 300 to 500 bp. Four microgram of anti-CREB-p or anti-specificity protein 1 (SP1; Millipore, Bedford, MA) or IgG (negative control; Millipore) were used. Oligonucleotide sequences are given in Table S1 in the online-only Data Supplement. 
Statistical Analysis
Results
Cellular sAC Localization
We initially determined expression levels of the cAMP-generating enzyme sAC in the vascular EC line EA.hy926 and the kidney proximal tubule epithelial cell line IHKE. EA.hy926 cells have been used commonly to investigate changes in endothelial function, [11] [12] [13] whereas IHKE cells have been introduced to study the function of renal Ca 2+ -, Na + -, and K + -channels. [25] [26] [27] We identified sAC protein in whole cell extract and, particularly, in the nucleus of EA.hy926 and IHKE cells (Figure 1) , with 3 protein isoforms designated A (≈55 kDa), B (≈65 kDa), and C (≈80 kDa). The nuclear accumulation of all 3 detected isoforms in ECs was increased by cAMP stimulation. Isoform B was detected hardly in crude cellular extracts of kidney cells but was significantly enriched in nuclear extracts. Interestingly, we observed a significant increase in sAC transcript upon 24-hour cAMP stimulation, whereas stimulation with protein kinase C-activating PMA remained ineffective (data not shown), suggesting PKA signaling rather than protein kinase C signaling to be involved in sAC expression regulation.
CRE-Mediated Transcriptional Activity Is Affected by sAC
Because sAC has been reported to stimulate CREB phosphorylation, 31 we investigated the impact of sAC on CRE-mediated transcriptional activity. A CRE reporter gene vector was used to detect changes in cellular CRE-mediated transcriptional activity ( Figure 2 ). We observed strong CRE-mediated transcriptional activity in ECs under basic conditions (Figure 2A ), which was less prominent in IHKE cells ( Figure 2B ). In both cell lines, PKA stimulation via cAMP led to significant activation of CRE-mediated transcriptional activity (Figure 2A and 2B; P<0.001). Treatment with the specific sAC inhibitor KH7 significantly reduced CRE promoter activity in ECs (P=0.0006; Figure 2A ) and CRE-mediated transcriptional activity was abrogated completely in kidney cells (P=0.0139; Figure 2B ) and could not be restored by cAMP. Our investigation of the impact of sAC inhibition on CREB phosphorylation (Ser 133 -CREB-p) and total cellular CREB by Western blot analyses showed that application of KH7 significantly reduced CREB-p in endothelial (P<0.05; Figure 2C ) and kidney cells (P<0.05; Figure 2D ) compared with mock control. The effects of KH7 on CREB phosphorylation were prevented by cAMP. The level of unphosphorylated CREB remained unaffected by KH7 and cAMP in either cell line ( Figure 2E and 2F). Notably, long-term treatment with KH7 (24 hours) resulted in an increase of Ser 133 -CREB-p in both cell lines ( Figure S1 ), suggesting a potential feedback mechanism.
Expression of Genes Regulating Endothelial Stiffness Depends on sAC Activity
To determine the regulatory effect of sAC on aldosterone-regulated genes, we analyzed the gene expression of Na resulted in a significant downregulation of ATP1A1 and SCNN1A ( Figure 3E ). To validate the results obtained by sAC inhibition via KH7, we performed sAC-specific small interfering RNA (siRNA) transfection experiments ( Figure 3B) . Consistently, the siRNA approach resulted in a significant downregulation of the expression of all genes (P<0.001), again with the exception of NR3C2 ( Figure 3B) .
Furthermore, we assessed the regulative effect of sAC inhibition in ECs under stimulatory conditions including aldosterone and cAMP ( Figure 3C and 3D) . Application of 200 pmol/L aldosterone exerted a strong activating effect on the expression of ADCY10, ATP1A1, ATP1B1, and SCNN1A, whereas expression of NR3C2 was increased slightly ( Figure 3C ). The observed gene expression activation was spironolactone-sensitive and was prevented effectively by KH7. Validation experiments were performed in human primary aortic ECs, in which aldosterone stimulation resulted in a comparable increase of ATP1A1, ATP1B1, and SCNN1A expression ( Figure 3F ). This finding is consistent with data from a comparative gene expression analysis of human umbilical vein ECs and EA.hy926, which concluded that EA.hy926 cells have retained the gene expression profile of primary ECs. 32 Short-term stimulation (2 and 4 hours) with cAMP significantly upregulated the expression of both genes coding for Na + /K + -ATPase subunits (ATP1A1, ATP1B1) and NR3C2 (P<0.05), whereas ADCY10 expression was not affected ( Figure 3D ). Notably, cAMP stimulation for 2 hours resulted in repression of NR3C2 and SCNN1A expression (P<0.01). The activating effect of cAMP was prevented by sAC inhibition with the exception of NR3C2. The inhibitory effects of KH7 in the presence of aldosterone were also observed on isolated glucocorticoid response element-and CRE-mediated gene expression ( Figure S2 ).
Because sAC inhibition led to a significant downregulation of ENaC-α and Na + /K + -ATPase-α gene expression (Figure 3 ) as well as a reduction in CREB-p and CRE-mediated promoter activity (Figure 2) , we analyzed potential sAC-dependent changes of CREB-p binding at SCNN1A 33 and ATP1A1 34 promoter regions in ChIP experiments. Because no reports existed that proved the binding of CREB-p to SCNN1A, we performed in silico analyses using PROMO 3.0.2. 35 The analysis revealed a conserved CRE motive located at position −784 of SCNN1A. For the ATP1A1 promoter, we analyzed the well-characterized PUC-1 region, including the known CRE motive. 34 Our ATP1A1 in silico analysis additionally suggested a SP1 binding site within the PUC-1 region. Our ChIP experiments in ECs revealed that CREB-p was bound to both promoters under basic conditions and binding of CREB-p was prevented by sAC inhibition (Figure 4) . Notably, SP1 binding at the ATP1A1 CRE motive was also prevented by sAC inhibition.
With respect to the significant effects of sAC inhibition on EC gene expression, we investigated the consequences of sAC knockdown in ECs and renal cells on the protein level ( Figure 5 ). Initially, we used an anti-sAC siRNA approach to confirm the identity of the detected sAC protein bands ( Figure 5A and 5B). Expression of all 3 identified sAC isoforms was significantly reduced by application of anti-sAC siRNA in both cell lines compared with scrambled siRNA (P<0.05). sAC inhibition by siRNA also affected ENaC-α and Na + /K + -ATPase-α levels. We observed a significant reduction of active ENaC-α as well as lower levels for glycosylated and ubiquitinylated ENaC-α 36 compared with mock control (P<0.05; Figure 5C and 5D). The protein level of Na + / K + -ATPase-α was reduced significantly in ECs (P<0.05; Figure 5E ), whereas no significant downregulation was observed in renal IHKE cells ( Figure 5F ). Comparable results were observed after 24-hour sAC inhibition by KH7, in that protein levels of active ENaC-α and Na + /K + -ATPase-α were reduced significantly in both cell lines compared with control (P<0.05; Figure S3 ).
ECs Are Softened by Inhibition of sAC
Based on the identified effect of sAC inhibition on the expression of genes known to be involved in the regulation of EC stiffness, we conducted AFM nano-indentation measurements of EA.hy926 ECs and mouse aorta ECs to determine the physiological effect of sAC inhibition. AFM is a nano-technique that measures stiffness, a mechanical property reflecting the physiological state of living cells. 12 The AFM tip was used as a mechanical sensor to quantify these properties in a multitude of individual ECs (20 cells per setting). The treatment of ECs with KH7 for 24 hours resulted in a significant endothelial softening compared with control conditions (P<0.05; Figure S4 ). Furthermore, the significant aldosterone-induced stiffening of mouse aorta ECs was prevented by sAC inhibition (P<0.05) and KH7-treated mouse aorta ECs were significantly softer than untreated cells in this setting (P<0.05; Figure 6 ). These results indicate that the observed effects on gene expression regulation via sAC inhibition in the presence of aldosterone translate into an overall endothelial softening.
Discussion
To the best of our knowledge, our study is the first to investigate the role of sAC in vascular ECs and the involvement of sAC in regulation of genes affecting endothelial stiffness.
We were able to demonstrate the following: (1) inhibition of sAC impairs CRE-mediated promoter activity; (2) inhibition of sAC affects CREB phosphorylation; (3) sAC regulates the expression of genes involved in endothelial stiffness; and (4) inhibition of sAC leads to endothelial softening.
Nuclear sAC as a Regulator of Active CRE Promoters
We detected sAC transcript and protein in vascular ECs and in the kidney cell line IHKE. Two sAC isoforms (≈55 and ≈80 kDa), identified by Hallows et al 20 in cell lysates of mpkCCDc14 kidney cells, were confirmed in IHKE cells, whereas we detected an additional isoform of ≈65 kDa predominantly in ECs. We confirmed the identity of all 3 detected protein bands by an anti-sAC siRNA approach. sAC has been reported to be involved in transmembrane adenylyl cyclases-independent cAMP signaling inside the mammalian cell nucleus, affecting CREB phosphorylation via PKA. 37, 38 Our experiments, including a CRE reporter vector and the sAC-specific inhibitor KH7, revealed potent inhibition of CRE-dependent promoter activation on sAC depletion. Previous studies have demonstrated that KH7 effectively inhibits sAC enzyme activity at concentrations of 10 to 30 μmol/L, whereas transmembrane adenylyl cyclases and soluble guanylyl cyclases remained unaffected. 39 The small molecule KH7 has been identified originally to display an IC 50 between 3 and 10 μmol/L toward the recombinant human ≈55 kDa sAC isoform. 40 Until today, the exact molecular mechanisms underlying the inhibitory effects of KH7 are unknown. Notably, application of cAMP in our CRE reporter vector experiments in kidney cells could not overcome sAC inhibition by KH7, which caused total abrogation of CRE-mediated transcriptional activity. The above-mentioned effects may be explained, at least in part, by the inhibition of enzymatic sAC cAMP production by KH7, but also by the alteration of a putative sAC/PKA complex with subsequent inhibition of respective promoter activities.
Inhibition of sAC Affects CREB Phosphorylation
In CRE reporter vector experiments, we observed that inhibition of sAC in ECs resulted in a less prominent effect on CRE-mediated transcription compared with that in IHKE cells. Furthermore, CRE-mediated transcriptional activity could only be restored by cAMP in ECs but not in renal cells. Because sAC has been suggested to act predominantly via cAMP-dependent PKA, which phosphorylates CREB exclusively at Ser 133 , 41 CRE-mediated transcriptional activation through CREB phosphorylation at Ser 133 may be the major pathway in renal cells. Our analysis of cellular CREB revealed that the level of total CREB was unaffected by short-term application of KH7 (1 hour), whereas Ser 133 -phosphorylated CREB was significantly reduced. Long-term KH7 treatment (24 hours) resulted in an increase of cellular Ser 133 -phosphorylated CREB in both cell lines, indicating the initiation of an alternative back-up mechanism for CREB phosphorylation under long-term sAC inhibition. In ECs, additional kinases involved in CREB phosphorylation at alternative residues different from Ser 133 might also be active. 42 Because cGMP-generating soluble guanylyl cyclases are unaffected by KH7, and sAC has been reported to be the only AC in the mammalian cell nucleus, 31 the endothelial soluble cGMP-dependent protein kinase I is a likely effector of alternative CRE-mediated transcription in ECs. 43, 44 An important function of cGMP in the vascular system has been stressed recently by the implication of phosphodiesterase 5 inhibitors, which increase intracellular cGMP concentration in disorders such as pulmonary and potentially essential hypertension. 45 Taking our findings into account, it is conceivable that sAC inhibition may as well affect positively the cellular balance between cAMP and cGMP, resulting in a potential reduction of blood pressure. 
Expression of Genes Regulating Endothelial Stiffness Depends on sAC
Individual reports have proposed a role for cAMP in gene expression regulation of SCNN1A, ATP1A1/-B1, and NR3C2, [15] [16] [17] 21 which are targets of endothelial aldosterone signaling. These observations, together with our results, suggested that sAC is involved in the regulation of all 4 genes and could affect endothelial stiffness. Consistently, we detected decreased levels of ATP1A1 and ATP1B1, NR3C2, SCNN1A, and sAC mRNA after 24 hours of KH7 administration in EA.hy926 cells. The results obtained with the sAC-specific inhibitor KH7 were validated using an anti-sAC siRNA approach, which led to a comparable strong reduction of all transcripts tested. In contrast to another report, 46 we detected aldosterone stimulation (200 pmol/L) of ECs to increase the expression of ADCY10, ATP1A1/B1, and SCNN1A after 2 hours, whereas NR3C2 increased after 4 hours. The increased mRNA levels of sAC, ATP1A1/B1, and SCNN1A were not detected after 4 hours of aldosterone stimulation, suggesting a feedback inhibition including either short mRNA half-lives or active degradation. The activating effect of aldosterone was prevented completely by KH7 and spironolactone. ATP1A1/B1, SCNN1A, and NR3C2 expression was also increased by cAMP stimulation, which was counterbalanced by sAC inhibition. Notably, NR3C2 expression remained activated in the presence of KH7. Our data obtained from ECs treated with anti-sAC siRNA and subsequent Western blot analyses suggest that the observed inhibition of ATP1A1 and SCNN1A gene expression may translate into a reduction of ENaC-α and Na + /K + -ATPase-α protein levels. Moreover, our ChIP experiments on CREB-p and SP1 binding to CRE motives demonstrate that sAC inhibition alters the interaction between transcription factors and the ATP1A1 and SCNN1A promoter regions. These findings may explain the observed reduction in ATP1A1 and SCNN1A gene expression on sAC inhibition.
Endothelium Is Softened by sAC Inhibition
Extending our molecular functional analyses on sAC in ECs, we hypothesized that sAC inhibition translates into relevant physiological effects through alteration of the mechanical properties of ECs. Using AFM measurements of an EC line as well as ECs of mice ex vivo aortae, we detected a significant softening of cells after inhibition of sAC. The observed effect of ≈8% difference in EC stiffness may be explained by the inhibitory effect on mRNA and protein levels of the analyzed genes, resulting in a mild but significant cell softening. This result is of clinical relevance because chronic endothelial stiffness is accompanied by endothelial dysfunction as one of the first measurable features of arteriosclerosis. 1, 3 Future in vivo studies will be required to demonstrate the importance of sAC in the modulation of EC stiffness.
Perspective
In conclusion, we propose that sAC is involved in cAMP-mediated regulation of aldosterone-sensitive genes in renal epithelial and vascular ECs. sAC contributes differently to the CRE-mediated transcriptional activation in both cell types, suggesting a cell type-specific function together with other CREB-phosphorylating kinases. Vascular sAC may be a key regulator of long-term arterial elasticity because the amount of functional cAMP-producing sAC determines cellular transcript and protein levels of ENaC-α and the α subunit of Na Transfection experiments were repeated at least two times in triplicates. sAC knockdown was performed by application of sAC-specific or scrambled siRNA (5 µM for 48h or 125 and 250 nM for 72h; Life Technologies, Darmstadt, Germany) using Oligofectamine (Invitrogen, Karlsruhe, Germany) in EA.hy926 and jetPRIME (PolyPlus) in IHKE cells. Transfection experiments were repeated at least three times in triplicates.
Real-time PCR
Total RNA was extracted using the NucleoSpin RNA II Extraction Kit (Macherey-Nagel, Düren, Germany). cDNA, generated from 1 µg of total RNA by Mul-V (Fermentas, St. LeonRot), was amplified in a 384-well format (standard real-time PCR conditions) in duplicates using Power SYBR Green (Applied Biosystem, Carlsbad, USA) on an Applied Biosystems 7500 Fast real-time PCR system. Relative quantification was calculated using the ΔΔCt method and GAPDH as endogenous control. The absence of non-specific amplification products was confirmed by agarose gel electrophoresis and generation of melting curves using the Applied Biosystems software. Oligonucleotides had an amplification efficiency of ≥90% (supplemental table S1).
Preparation of nuclear protein extracts
In brief, cells were resuspended in a "low salt" buffer (10 mM HEPES pH 7.9, 10 mM KCl, Germany), lysed by addition of 0.05% NP40 and centrifuged. Intact nuclei were incubated in "high salt" buffer (20 mM HEPES pH 7.9, 0.2 mM EDTA, 1 mM DTT, 420 mM NaCl, 1.5 mM MgCl 2 , 0.5 mM PMSF, Roche 'Complete', 25% glycerol) and proteins were harvested by centrifugation. experiments. β-actin served as gel loading control.
Western blot
